US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

INVESCO BIOTECHNOLOGY & GENOME ETF

94.70

-2.3429-2.41%

Pre-market: 94.700.00000.00%07:37 EDT

Volume:8K

Turnover:765.28K

Market Cap:413.82M

PE:52.81

High:97.38

Open:97.38

Low:94.27

Close:97.04

52wk High:98.82

52wk Low:70.01

Shares:4.37M

Float Shares:4.37M

Volume Ratio:0.48

T/O Rate:0.18%

Dividend:1.34

Dividend Rate:1.41%

EPS(TTM):1.79

EPS(LYR):18.65

ROE:24.76%

ROA:0.08%

PB:1.67

PE(LYR):5.08

Loading ...

Overview Company News Filings

Amgen’s AMG 513 Obesity Trial Reaches Phase 1 Completion, Adding a New Angle to the Weight-Loss Drug Race

Royalty Pharma EVP Research & Investments Marshall Urist Sells $235,594 of Class a Shares

Biogen Inc. Stock Outperforms Competitors on Strong Trading Day

IntegraGen Faces Judicial Liquidation as Court Weighs Takeover Bids

Vortex Energy Launches Study on Natural Hydrogen and Helium at Robinsons River Salt Project

Biogen Inc. Stock Underperforms Friday When Compared to Competitors

Amgen Inc. Stock Underperforms Friday When Compared to Competitors

NASDAQ Top and Bottom Performing Stocks at About 02:45 P.m. EDT on 2026-10-02

Biogen Says Litifilimab Safety Profile Consistent with no New Safety Signals Identified

Biogen's Experimental Lupus Drug Shows Benefit Against Skin Symptoms

Biogen’s Salanersen Trial Strengthens Its SMA Pipeline Outlook

Amgen’s Evolocumab Study Signals Quiet Efficiency Gains for Cholesterol Franchise

Biogen Says Litifilimab Posts Sustained Skin Clearance in 52-Week Phase 2 Cutaneous Lupus Study

Biogen - 28.8% of Participants Achieve 70% or Greater Reduction in Clasi a at Week 52

THOMSON REUTERS

Biogen’s Litifilimab Demonstrates Rapid and Durable Efficacy in New 52-Week Phase 2 Data from Ongoing Phase 2/3 Amethyst Study, Reinforcing Its Potential as a First-in-Class Therapy for Cutaneous Lupus Erythematosus~

THOMSON REUTERS

Biogen - Serious Adverse Events Occurred in 3.4% of Participants During 52-Week Treatment Period

THOMSON REUTERS

Biogen - 33.7% of Crossover Participants Report Clear or Almost Clear Skin at Week 52

THOMSON REUTERS

Vertex Minerals lodges 2026 corporate governance statement with ASX

Sino Biopharmaceutical Stock Falls 2.3% in Hong Kong, Underperforms Competitors

Quantum Computing is Having a Moment. What to Know About the Hottest Sector After AI.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://hk.tigeractivity.com/stock/PBE/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"PBE","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PBE\",,,,,undefined,":{"symbol":"PBE","market":"US","secType":"STK","nameCN":"INVESCO BIOTECHNOLOGY & GENOME ETF","latestPrice":94.6964,"timestamp":1791316800000,"preClose":97.0393,"halted":0,"volume":8054,"hourTrading":{"tag":"盘前","latestPrice":94.6964,"preClose":94.6964,"latestTime":"07:37 EDT","volume":3,"amount":284.0892,"timestamp":1791373035982,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.0241438262642043,"floatShares":4370000,"shares":4370000,"eps":1.793292,"marketStatus":"Pre-Mkt","change":-2.3429,"latestTime":"10-07 08:02:47 EDT","open":97.38,"high":97.38,"low":94.2701,"amount":765277.06604,"amplitude":0.032048,"askPrice":108.21,"askSize":100,"bidPrice":81.34,"bidSize":100,"shortable":3,"etf":1,"ttmEps":1.793292,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1791379800000},"marketStatusCode":1,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":94.6964,"sharesOutstanding":3180000,"nav":96.99046,"aum":421908501,"dividendRate":0.0141,"bidAskSpread":0.00204,"preHourTrading":{"tag":"盘前","latestPrice":94.6964,"preClose":94.6964,"latestTime":"07:37 EDT","volume":3,"amount":284.0892,"timestamp":1791373035982,"change":0,"changeRate":0,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":94.2701,"preClose":94.6964,"latestTime":"19:30 EDT","volume":13,"amount":1230.2495,"timestamp":1791329402746,"change":-0.4263,"changeRate":-0.004502,"amplitude":0},"volumeRatio":0.47928494409220274,"impliedVol":0.1691,"impliedVolPercentile":0.264},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PBE\",,,,,undefined,":{"symbol":"PBE","floatShares":4370000,"roa":"0.08%","roe":"24.76%","lyrEps":18.654418,"volumeRatio":0.47928494409220274,"shares":4370000,"dividePrice":1.3352,"high":97.38,"amplitude":0.032048,"preClose":97.0393,"low":94.2701,"week52Low":70.01,"pbRate":"1.67","psRate":"241.06","week52High":98.82,"institutionHeld":0.2552,"latestPrice":94.6964,"eps":1.793292,"divideRate":0.0141,"volume":8054,"delay":0,"ttmEps":1.793292,"open":97.38,"prevYearClose":82.15,"prevWeekClose":95.07,"prevMonthClose":97.2888,"prevQuarterClose":97.2888,"fiveDayClose":97.1647,"twentyDayClose":94.89,"sixtyDayClose":90.5556},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PBE\",params:#limit:5,,,undefined,":[{"date":"2026-09-21","symbol":"PBE","amount":0.01867,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-09-21","defaultRemindTime":1789997400000,"name":"INVESCO BIOTECHNOLOGY & GENOME ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-09-25","payableDate":"2026-09-21","currency":"USD","dateTimestamp":1789963200000,"payDate":"2026-09-25"},{"date":"2026-06-22","symbol":"PBE","amount":0.81061,"announcedDate":"2026-06-18","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-22","defaultRemindTime":1782135000000,"name":"INVESCO BIOTECHNOLOGY & GENOME ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-26","payableDate":"2026-06-22","currency":"USD","dateTimestamp":1782100800000,"payDate":"2026-06-26"},{"date":"2026-03-23","symbol":"PBE","amount":0.08244,"announcedDate":"2026-03-20","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-03-23","defaultRemindTime":1774272600000,"name":"INVESCO BIOTECHNOLOGY & GENOME ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-27","payableDate":"2026-03-23","currency":"USD","dateTimestamp":1774238400000,"payDate":"2026-03-27"},{"date":"2025-12-22","symbol":"PBE","amount":0.41972,"announcedDate":"2025-12-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-22","defaultRemindTime":1766413800000,"name":"INVESCO BIOTECHNOLOGY & GENOME ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-26","payableDate":"2025-12-22","currency":"USD","dateTimestamp":1766379600000,"payDate":"2025-12-26"},{"date":"2025-09-22","symbol":"PBE","amount":0.23409,"announcedDate":"2025-09-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-22","defaultRemindTime":1758547800000,"name":"INVESCO BIOTECHNOLOGY & GENOME ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-26","payableDate":"2025-09-22","currency":"USD","dateTimestamp":1758513600000,"payDate":"2025-09-26"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PBE\",market:\"US\",,,undefined,":[{"executeDate":"2016-12-16","recordDate":"2016-12-20","paymentDate":"2016-12-30","value":0.1208,"currency":"USD"},{"executeDate":"2017-03-17","recordDate":"2017-03-21","paymentDate":"2017-03-31","value":0.05552,"currency":"USD"},{"executeDate":"2017-06-16","recordDate":"2017-06-20","paymentDate":"2017-06-30","value":0.21532,"currency":"USD"},{"executeDate":"2018-09-24","recordDate":"2018-09-25","paymentDate":"2018-09-28","value":0.00207,"currency":"USD"},{"executeDate":"2020-03-23","recordDate":"2020-03-24","paymentDate":"2020-03-31","value":0.02898,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"PBE\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"PBE\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2673503870","title":"Amgen’s AMG 513 Obesity Trial Reaches Phase 1 Completion, Adding a New Angle to the Weight-Loss Drug Race","url":"https://stock-news.laohu8.com/highlight/detail?id=2673503870","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673503870?lang=en_us&edition=fundamental","pubTime":"2026-10-07 00:31","pubTimestamp":1791304260,"startTime":"0","endTime":"0","summary":"Amgen Inc ($AMGN) announced an update on their ongoing clinical study. The study, titled “A Phase 1, Randomized, Double-blind, Placebo-controlled, ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/amgens-amg-513-obesity-trial-reaches-phase-1-completion-adding-a-new-angle-to-the-weight-loss-drug-race?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/amgens-amg-513-obesity-trial-reaches-phase-1-completion-adding-a-new-angle-to-the-weight-loss-drug-race?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1023059063.AUD","BBH","LU2242652126.USD","SG9999001440.SGD","PBE","BIB","IE00BFTCPJ56.SGD","IE0009355771.USD","PJP","AMGN","IBBQ","TBXU","BK4139","LU1057294990.SGD","IE00B2B36J28.USD","LU0109394709.USD","BK4585","IE00B4R5TH58.HKD","LU2112291526.USD","BK4581","BK4566","LU1983299246.USD","LU0058720904.USD","IBB","IE0002141913.USD","BK4533","LU0320765992.SGD","LU0889565916.HKD","BK4534","LU1061106388.HKD","BK4588","LU2089984988.USD","LU0122379950.USD","LU0289739699.SGD","LU0868494617.USD","BK4599","IE00BJT1NW94.SGD","LU2468319806.SGD","LU1571399168.USD","IE00BJJMRZ35.SGD","LU2242646821.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673082866","title":"Royalty Pharma EVP Research & Investments Marshall Urist Sells $235,594 of Class a Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2673082866","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673082866?lang=en_us&edition=fundamental","pubTime":"2026-10-06 05:13","pubTimestamp":1791234817,"startTime":"0","endTime":"0","summary":"Royalty Pharma EVP Research & Investments Marshall Urist sells $235,594 of Class A sharesRoyalty Pharma EVP, Research & Investments Marshall Urist sold 4,126 Class A ordinary shares on Oct. 5, 2026 at","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261005:nNDL2PbZG5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Royalty Pharma EVP Research & Investments Marshall Urist Sells $235,594 of Class a Shares","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PBE","BK4007","IHE","RPRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673842960","title":"Biogen Inc. Stock Outperforms Competitors on Strong Trading Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2673842960","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673842960?lang=en_us&edition=fundamental","pubTime":"2026-10-06 04:56","pubTimestamp":1791233760,"startTime":"0","endTime":"0","summary":"DJ Biogen Inc. Stock Outperforms Competitors On Strong Trading DayThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Biogen Inc.  rallied 1.69% to $223.59 Monday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index  rising 0.66% to 7,773.95 and the Dow Jones Industrial Average  rising 0.18% to 51,267.90.The stock's rise snapped a four-day losing streak.Biogen Inc. closed 2.99% short of its 52-week high of $230.49, which the company achieved on September 28th.The stock outperformed some of its competitors Monday, as Johnson & Johnson  fell 1.21% to $252.93, Pfizer Inc.  fell 1.40% to $27.41, and AbbVie Inc.  rose 1.12% to $265.76.Trading volume  remained 12,733 below its 50-day average volume of 949,724.Data source: Dow Jones Market Data, FactSet. Data compiled October 5, 2026.","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4533","LU0889565916.HKD","LU0320765992.SGD","BMED","IE00B19Z9P08.USD","IE00B19Z9Z06.USD","IE00B894F039.SGD","LU0234570918.USD","BK4532","PBE","BIIB","BK4588","BK4139","BK4585","LU0109394709.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673086069","title":"IntegraGen Faces Judicial Liquidation as Court Weighs Takeover Bids","url":"https://stock-news.laohu8.com/highlight/detail?id=2673086069","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673086069?lang=en_us&edition=fundamental","pubTime":"2026-10-06 01:38","pubTimestamp":1791221905,"startTime":"0","endTime":"0","summary":"IntegraGen SA ( ($FR:ALINT) ) has shared an update. IntegraGen, the French genomics specialist in cancer and rare genetic diseases, is a major prov...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/integragen-faces-judicial-liquidation-as-court-weighs-takeover-bids?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/integragen-faces-judicial-liquidation-as-court-weighs-takeover-bids?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TARK","FWD","IDNA","BMED","GNMX","PBE","DARP","GNOM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673086684","title":"Vortex Energy Launches Study on Natural Hydrogen and Helium at Robinsons River Salt Project","url":"https://stock-news.laohu8.com/highlight/detail?id=2673086684","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673086684?lang=en_us&edition=fundamental","pubTime":"2026-10-06 00:38","pubTimestamp":1791218328,"startTime":"0","endTime":"0","summary":"Vortex Energy Corp. ( ($TSE:VRTX) ) has issued an update. Vortex Energy Corp. has commissioned Lonquist Field Service (Canada), ULC to conduct a de...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/vortex-energy-launches-study-on-natural-hydrogen-and-helium-at-robinsons-river-salt-project?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/vortex-energy-launches-study-on-natural-hydrogen-and-helium-at-robinsons-river-salt-project?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2324357040.USD","BK4588","LU0417517546.SGD","BK4139","IE00B19Z3581.USD","IE00B4R5TH58.HKD","SG9999001176.SGD","LU2362541513.USD","IE00B19Z9P08.USD","LU0109394709.USD","BIB","VRTX","GNMX","IE0002270589.USD","BK4585","LU2089984988.USD","IE00BJT1NW94.SGD","IE00B894F039.SGD","TBXU","LU1778281490.HKD","LU0320765992.SGD","BK4533","IE0009355771.USD","LU1585245621.USD","LU0889565916.HKD","LU2362541273.HKD","HYDR","IBB","LU0079474960.USD","IE0002141913.USD","LU2456880835.USD","IE00BFTCPJ56.SGD","LU2468319806.SGD","BBH","IE00B19Z9Z06.USD","LU2362540622.SGD","SG9999013999.USD","LU1035775433.USD","BK4567","LU0058720904.USD","LU1093756168.USD","BK4532","LU2237438978.USD","LU2236285917.USD","IBBQ","PBE","LU0234570918.USD","IDNA","SGXZ57979304.SGD","IE00BZ9MQY76.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672749086","title":"Biogen Inc. Stock Underperforms Friday When Compared to Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2672749086","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672749086?lang=en_us&edition=fundamental","pubTime":"2026-10-03 04:56","pubTimestamp":1790974560,"startTime":"0","endTime":"0","summary":"DJ Biogen Inc. Stock Underperforms Friday When Compared To CompetitorsThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Biogen Inc.  slid 1.32% to $219.88 Friday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index  rising 0.73% to 7,722.72 and the Dow Jones Industrial Average  rising 0.49% to 51,176.96.This was the stock's fourth consecutive day of losses.Biogen Inc. closed 4.60% short of its 52-week high of $230.49, which the company achieved on September 28th.The stock underperformed when compared to some of its competitors Friday, as Johnson & Johnson  fell 1.02% to $256.03, Pfizer Inc.  fell 1.14% to $27.80, and AbbVie Inc.  rose 1.11% to $262.82.Trading volume  remained 180,740 below its 50-day average volume of 954,757.Data source: Dow Jones Market Data, FactSet. Data compiled October 2, 2026.","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BMED","LU0109394709.USD","BIIB","LU0234570918.USD","BK4533","LU0320765992.SGD","BK4585","LU0889565916.HKD","BK4532","PBE","BK4139","IE00B19Z9Z06.USD","IE00B19Z9P08.USD","IE00B894F039.SGD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672749900","title":"Amgen Inc. Stock Underperforms Friday When Compared to Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2672749900","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672749900?lang=en_us&edition=fundamental","pubTime":"2026-10-03 04:34","pubTimestamp":1790973240,"startTime":"0","endTime":"0","summary":"DJ Amgen Inc. Stock Underperforms Friday When Compared To CompetitorsThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Amgen Inc.  slipped 1.04% to $403.04 Friday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index  rising 0.73% to 7,722.72 and the Dow Jones Industrial Average  rising 0.49% to 51,176.96.This was the stock's third consecutive day of losses.Amgen Inc. closed 9.84% short of its 52-week high of $447.03, which the company achieved on August 25th.The stock demonstrated a mixed performance when compared to some of its competitors Friday, as Johnson & Johnson  fell 1.02% to $256.03, Pfizer Inc.  fell 1.14% to $27.80, and AbbVie Inc.  rose 1.11% to $262.82.Trading volume  eclipsed its 50-day average volume of 2.9 M.Data source: Dow Jones Market Data, FactSet. Data compiled October 2, 2026.","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1983299246.USD","TBXU","LU2468319806.SGD","IE00BJT1NW94.SGD","PBE","LU1057294990.SGD","LU2089984988.USD","LU2242652126.USD","LU1061106388.HKD","LU1571399168.USD","IE0009355771.USD","BK4599","LU0868494617.USD","BK4533","BK4585","AMGN","BK4139","IE00BFTCPJ56.SGD","IBBQ","BIB","LU2112291526.USD","LU0289739699.SGD","LU0889565916.HKD","LU0122379950.USD","LU1023059063.AUD","IE00BJJMRZ35.SGD","PJP","BK4534","IBB","LU0058720904.USD","LU2242646821.SGD","BK4588","04332","BK4581","BBH","BK4566","IE0002141913.USD","IE00B2B36J28.USD","IE00B4R5TH58.HKD","SG9999001440.SGD","LU0320765992.SGD","LU0109394709.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672450627","title":"NASDAQ Top and Bottom Performing Stocks at About 02:45 P.m. EDT on 2026-10-02","url":"https://stock-news.laohu8.com/highlight/detail?id=2672450627","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672450627?lang=en_us&edition=fundamental","pubTime":"2026-10-03 02:45","pubTimestamp":1790966707,"startTime":"0","endTime":"0","summary":"BUZZ - Nasdaq top and bottom performing stocks at about 02:45 p.m. EDT on 2026-10-02Nasdaq 100.NDXTop PerformersPercent ChangeTeradyne, Inc.TER.OQ+8.2%Space Exploration Technologies CorpSPCX.OQ+7.5%Monolithic Power Systems IncMPWR.OQ+5.5%ARM Holdings PLCARM.OQ+4.9%Tesla IncTSLA.OQ+4.7%Bottom PerformersPercent ChangeSeagate Technology Holdings PLCSTX.OQ-10.8%Western Digital CorpWDC.OQ-10.2%Alnylam Pharmaceuticals, Inc.ALNY.OQ-4.0%SanDisk CorporationSNDK.OQ-3.8%AppLovin CorporationAPP.OQ-3.5%The Nasdaq 100.NDXgained 283.70 points, or 0.93%, to 30,785.72 and recorded 6 new highs and 3 new lows. 61 stocks rose and 40 fell as advancing issues outnumbered decliners by a about a 1.5-to-1 ratio.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261002:nL8N45O1NA:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1815336760.USD","IE0034235303.USD","LU1035773651.USD","IDRV","BK4608","IE00BSNM7G36.USD","LU0323591593.USD","LU0072461881.USD","SNXX","IE00B19Z9Z06.USD","SCHM","LU0056508442.USD","SG9999014013.SGD","IE00BN0W2T93.GBP","LU2357305700.SGD","IE00BMPRXR70.SGD","LU0823414478.USD","TER","LU0077335932.USD","LU0154236417.USD","LU2168564065.EUR","BK4592","LU2420271590.USD","LU2272731782.SGD","TMSL","IE00B1BXHZ80.USD","LU0081259029.USD","TSLT","LU0082616367.USD","LOFF","LU1778281490.HKD","SSPC","PTF","SNK","SG9999015978.USD","LU1267930730.SGD","LU1983260115.SGD","LU2087625088.SGD","STXX","BK4613","BK4574","LU0240878834.USD","LU0708995401.HKD","TERG","TSLR","LU0097036916.USD","WARP","ALNY","QQQA","LU1066051498.USD","LU0203345920.USD","LU0820561909.HKD","LU1674673691.USD","LU0266013472.USD","LU1066053197.SGD","LU2089985449.USD","LU2471134952.CNY","ARMA","LU2290526834.HKD","SPCF","BK4141","IE00B3QW5Z07.USD","WATS","LU0889565916.HKD","IE00BMPRXQ63.HKD","IE00BKPKM429.USD","LU2168564222.USD","LU0353189763.USD","SPAX","LU1861558580.USD","LU0444971666.USD","LU2210149790.SGD","WLDR","LU1670628061.USD","IE00BWXC8680.SGD","LU0964807845.USD","CRSH","SMOG","IE00BD6J9T35.USD","LU0210536198.USD","SPCX","MPWC","FSMD","LU2360106780.USD","SNDQ","LU2473716301.USD","LU1823568750.SGD","ELOL","LU2236285917.USD","IE00B19Z8X17.USD","BK4527","BK4588","BK4170","LU1720051017.SGD","LU0162691827.USD","LU1366192091.USD","CLOD","07766","IE00B19Z8W00.USD","SG9999015986.USD","BK4581","LU1861220033.SGD","LU2322448957.HKD","ARMW","NDAQ","APPX","ARMU","LU1429558221.USD","TESC","DISK","LU0353189680.USD","BK4551","LU0882574055.USD","IE00BQXX3F31.USD","TSLQ","TSII","LU0476273544.USD","SNDU","BCDF","LU2063271972.USD","TRFK","IE00BK4W5M84.HKD","LU2471134523.USD","SPRX","RULE","HK0000914660.USD","TESL","LU0689472784.USD","LU2168564149.EUR","TSLG","CNAV","LU0823411888.USD","SNDG","LU1914381329.SGD","EGGY","CNEQ","AIPI","LU0444973449.USD","GB00BDT5M118.USD","LU1046421795.USD","LU0348723411.USD","BK4089","IE00BMPRXN33.USD","SG9999015945.SGD","WDC","TSLA","WDCX","IE00B64PRP62.GBP","FCUS","LU0957808578.USD","BK4139","TSDD","STXL","LU1674673428.USD","IE00BK4W5L77.USD","LU1861215975.USD","TEST","LU2543165471.USD","IE00B19Z9P08.USD","LU1670627923.USD","SPCU","FDTX","BK4598","BK4511","LU0320765059.SGD","BK4023","LU2360107168.USD","MPWR","IE00BQXX3C00.GBP","LU2210150020.SGD","LU0053666078.USD","LU0006061336.USD","IE00BZ9MQY76.HKD","BK4604","LU2095319765.USD","LU2272731600.USD","LOFD","BK4585","IE00BQXX3D17.EUR","SPCG","XDAT","ARMG","SPCH","BK4555","LU0672654240.SGD","LU1551013425.SGD","LU2456880835.USD","BK4516","LU0114720955.EUR","BK4612","LU1435385759.SGD","IE00BN0W2V16.EUR","LU1629891620.HKD","OPTZ","LU2168564495.EUR","SPCQ","LU0345769631.USD","07366","LIT","LU1839511570.USD","LU2750360997.AUD","STXU","LU2756315664.SGD","LU0240877869.USD","LU0198837287.USD","CGGO","LU0203347892.USD","LU2249611893.SGD","IE00B19Z9505.USD","LU2471134796.USD","IE00B894F039.SGD","GNMX","LU0345770308.USD","LU2322448791.USD","SNDC","LU1069347547.HKD","EPAI","TSLS","LU1548497426.USD","MARS","LU1852331112.SGD","SNDK","LU0109394709.USD","LU0719512351.SGD","LU1992135399.USD","LU2213496289.HKD","TSLZ","LU1066051811.HKD","LU1235294995.USD","LU0820561818.USD","SPCM","LU2417539215.USD","BK4548","IE00BJLML261.HKD","LU0943347566.SGD","IE00B1XK9C88.USD","TSL","LU2602419157.SGD","LU1861559042.SGD","LU2168563687.JPY","LU1066051225.USD","LU1551013342.USD","SG9999014021.USD","TSLO","BK4550","STSLAmain","LU0316494557.USD","APPC","WANT","BK4534","LU2403377893.USD","SPAL","TSLW","LU1232071149.USD","BK4099","LU2108987350.USD","LU0234572021.USD","BK4112","SG9999014039.USD","LU0345769128.USD","TERC","ORBX","TSLL","SCHA","BK4512","BK4009","DSPC","TSYY","LU2750360641.GBP","LU2931357623.SGD","BK4147","BK4533","STX","LU2326559502.SGD","BK4609","LU1720051108.HKD","APP","LU2250418816.HKD","09766","SG9999014005.SGD","LU0109391861.USD","QQQG","MPWX","LU0820562030.AUD","LU0274383776.USD","LU2023250330.USD","LU2896262040.SGD","TSLP","LU1642822529.SGD","LU2272731865.HKD","LU2087621335.USD","IE00BN0W2W23.USD","LU2471134879.HKD","LU0963586101.USD","ARM","LU0054578231.USD","BK4543","LU0314104364.USD","TSLY","FDRV","09366","DRMY","TSLI","LU0234570918.USD","PBE","LU1145028129.USD","COWG","HK0000914686.HKD","TLA","LU2756315318.SGD","YSPC","SG9999015952.SGD","LU0320765992.SGD","IE00BGHQF748.EUR","WDCC","LU1992135472.HKD","LU0345770993.USD","LU0133085943.USD","BK4539","LU0466842654.USD","WSPC","LU2462157665.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672301745","title":"Biogen Says Litifilimab Safety Profile Consistent with no New Safety Signals Identified","url":"https://stock-news.laohu8.com/highlight/detail?id=2672301745","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672301745?lang=en_us&edition=fundamental","pubTime":"2026-10-03 01:25","pubTimestamp":1790961920,"startTime":"0","endTime":"0","summary":"BRIEF-Biogen Says Litifilimab Safety Profile Consistent With No New Safety Signals IdentifiedOct 2 (Reuters)-Biogen Inc.BIIB.O:BIOGEN’S LITIFILIMAB DEMONSTRATES RAPID AND DURABLE EFFICACY IN NEW 52-WE","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261002:nFWN45O0A5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0234570918.USD","LU0889565916.HKD","BK4533","IE00B19Z9P08.USD","BMED","BK4532","BIIB","BK4139","BK4588","IE00B894F039.SGD","IE00B19Z9Z06.USD","PBE","LU0109394709.USD","BK4585","LU0320765992.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672743907","title":"Biogen's Experimental Lupus Drug Shows Benefit Against Skin Symptoms","url":"https://stock-news.laohu8.com/highlight/detail?id=2672743907","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672743907?lang=en_us&edition=fundamental","pubTime":"2026-10-03 00:39","pubTimestamp":1790959165,"startTime":"0","endTime":"0","summary":"Biogen's experimental lupus drug shows benefit against skin symptomsOct 2 (Reuters)-BiogenBIIB.Osaid on Friday its experimental drug showed durable improvement in skin symptoms among patients with a t","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261002:nL4N45O11Z:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0109394709.USD","BK4532","IE00B19Z9P08.USD","BK4139","BK4585","IE00B19Z9Z06.USD","IE00B894F039.SGD","BK4588","BIIB","LU0320765992.SGD","LU0889565916.HKD","BK4533","BMED","PBE","LU0234570918.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672743138","title":"Biogen’s Salanersen Trial Strengthens Its SMA Pipeline Outlook","url":"https://stock-news.laohu8.com/highlight/detail?id=2672743138","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672743138?lang=en_us&edition=fundamental","pubTime":"2026-10-03 00:31","pubTimestamp":1790958685,"startTime":"0","endTime":"0","summary":"Biogen Inc. ($BIIB) announced an update on their ongoing clinical study. Biogen Inc. (BIIB) is running a Phase 3 study of salanersen (BIIB115) in p...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/biogens-salanersen-trial-strengthens-its-sma-pipeline-outlook?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/biogens-salanersen-trial-strengthens-its-sma-pipeline-outlook?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","BK4532","LU0889565916.HKD","LU0320765992.SGD","IE00B19Z9Z06.USD","BIIB","BK4585","BK4139","IE00B894F039.SGD","PBE","BK4533","LU0109394709.USD","IE00B19Z9P08.USD","LU0234570918.USD","BMED"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672174313","title":"Amgen’s Evolocumab Study Signals Quiet Efficiency Gains for Cholesterol Franchise","url":"https://stock-news.laohu8.com/highlight/detail?id=2672174313","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672174313?lang=en_us&edition=fundamental","pubTime":"2026-10-03 00:30","pubTimestamp":1790958636,"startTime":"0","endTime":"0","summary":"Amgen Inc ($AMGN) announced an update on their ongoing clinical study. Amgen’s AMGN Evolocumab Study Highlights Subtle Edge in Cholesterol Drug Del...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/amgens-evolocumab-study-signals-quiet-efficiency-gains-for-cholesterol-franchise?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/amgens-evolocumab-study-signals-quiet-efficiency-gains-for-cholesterol-franchise?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0889565916.HKD","TBXU","SG9999001440.SGD","AMGN","IE00B4R5TH58.HKD","PJP","IE00BJJMRZ35.SGD","LU0320765992.SGD","IE0002141913.USD","IE00BFTCPJ56.SGD","IBBQ","LU1057294990.SGD","LU2112291526.USD","BK4533","PBE","BK4581","IE00B2B36J28.USD","LU2242646821.SGD","LU2242652126.USD","LU2468319806.SGD","LU1571399168.USD","BIB","LU0289739699.SGD","BBH","IE0009355771.USD","BK4585","LU1983299246.USD","IE00BJT1NW94.SGD","BK4588","LU0058720904.USD","BK4139","LU1023059063.AUD","LU0109394709.USD","BK4534","BK4599","IBB","LU0868494617.USD","LU2089984988.USD","LU1061106388.HKD","LU0122379950.USD","BK4566"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672748656","title":"Biogen Says Litifilimab Posts Sustained Skin Clearance in 52-Week Phase 2 Cutaneous Lupus Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2672748656","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672748656?lang=en_us&edition=fundamental","pubTime":"2026-10-02 23:20","pubTimestamp":1790954443,"startTime":"0","endTime":"0","summary":"Biogen says litifilimab posts sustained skin clearance in 52-week Phase 2 cutaneous lupus studyBiogen reported 52-week Phase 2 AMETHYST data for litifilimab in cutaneous lupus erythematosus, previousl","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261002:nNDL57zG2F:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","LU2210150020.SGD","LU2095319765.USD","BIIB","IE00BN0W2T93.GBP","NDAQ","SG9999014021.USD","BK4588","BK4532","IE00BQXX3F31.USD","IE00BQXX3D17.EUR","SG9999014013.SGD","IE00B3QW5Z07.USD","PBE","LU0314104364.USD","BMED","IE00B19Z9Z06.USD","IE00BN0W2W23.USD","LU0889565916.HKD","LU2210149790.SGD","BK4533","IE00BN0W2V16.EUR","LU0234570918.USD","BK4112","SG9999014005.SGD","IE00BGHQF748.EUR","LU0109394709.USD","LU0320765992.SGD","BK4139","BCDF","IE00B19Z9P08.USD","IE00BKPKM429.USD","IE00BQXX3C00.GBP","SG9999014039.USD","IE00B64PRP62.GBP","IE00B894F039.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672748638","title":"Biogen - 28.8% of Participants Achieve 70% or Greater Reduction in Clasi a at Week 52","url":"https://stock-news.laohu8.com/highlight/detail?id=2672748638","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672748638?lang=en_us&edition=fundamental","pubTime":"2026-10-02 23:20","pubTimestamp":1790954408,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261002:nFWN45O0A5:5","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4588","BK4139","BMED","IE00B19Z9Z06.USD","LU0320765992.SGD","LU0889565916.HKD","BIIB","LU0234570918.USD","PBE","BK4585","IE00B894F039.SGD","BK4532","LU0109394709.USD","IE00B19Z9P08.USD","BK4533"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672748636","title":"Biogen’s Litifilimab Demonstrates Rapid and Durable Efficacy in New 52-Week Phase 2 Data from Ongoing Phase 2/3 Amethyst Study, Reinforcing Its Potential as a First-in-Class Therapy for Cutaneous Lupus Erythematosus~","url":"https://stock-news.laohu8.com/highlight/detail?id=2672748636","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672748636?lang=en_us&edition=fundamental","pubTime":"2026-10-02 23:20","pubTimestamp":1790954408,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261002:nFWN45O0A5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BMED","BK4532","LU0234570918.USD","IE00B19Z9Z06.USD","IE00B19Z9P08.USD","IE00B894F039.SGD","BK4588","BK4585","BK4533","LU0109394709.USD","LU0889565916.HKD","PBE","BIIB","LU0320765992.SGD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672687748","title":"Biogen - Serious Adverse Events Occurred in 3.4% of Participants During 52-Week Treatment Period","url":"https://stock-news.laohu8.com/highlight/detail?id=2672687748","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672687748?lang=en_us&edition=fundamental","pubTime":"2026-10-02 23:20","pubTimestamp":1790954408,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261002:nFWN45O0A5:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0109394709.USD","LU0889565916.HKD","PBE","BK4588","IE00B19Z9P08.USD","BK4533","IE00B894F039.SGD","IE00B19Z9Z06.USD","BK4139","BK4585","BK4532","LU0320765992.SGD","LU0234570918.USD","BIIB","BMED"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672574863","title":"Biogen - 33.7% of Crossover Participants Report Clear or Almost Clear Skin at Week 52","url":"https://stock-news.laohu8.com/highlight/detail?id=2672574863","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672574863?lang=en_us&edition=fundamental","pubTime":"2026-10-02 23:20","pubTimestamp":1790954408,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261002:nFWN45O0A5:6","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PBE","LU0234570918.USD","IE00B19Z9Z06.USD","BK4533","BIIB","LU0889565916.HKD","BK4585","BMED","BK4588","IE00B19Z9P08.USD","LU0109394709.USD","BK4139","LU0320765992.SGD","IE00B894F039.SGD","BK4532"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672713165","title":"Vertex Minerals lodges 2026 corporate governance statement with ASX","url":"https://stock-news.laohu8.com/highlight/detail?id=2672713165","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672713165?lang=en_us&edition=fundamental","pubTime":"2026-10-02 17:08","pubTimestamp":1790932081,"startTime":"0","endTime":"0","summary":"The latest update is out from Vertex Minerals Ltd. ( ($AU:VTX) ). Vertex Minerals Ltd. has lodged its Appendix 4G and 2026 Corporate Governance Sta...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/vertex-minerals-lodges-2026-corporate-governance-statement-with-asx?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/vertex-minerals-lodges-2026-corporate-governance-statement-with-asx?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NUSC","IE00B19Z3B42.SGD","ESGV","IBBQ","SUSA","ESGA","BIB","SG9999013999.USD","LU0432979614.USD","MDCP","SSPX","VERX","CDEI","HAPY","BK4585","CVLC","ESML","VOTE","ESG","NUDV","CHRI","JSTC","GNMX","LU1778281490.HKD","IE00B4R5TH58.HKD","MTX","LU0320765992.SGD","BBH","IE00B2B36J28.USD","DSI","LU1035775433.USD","PEMX","TBXU","IBB","IE0002270589.USD","SGXZ57979304.SGD","EXEQ","BK4139","LU2417539215.USD","HAPI","BK4567","IDNA","LOPP","SG9999001176.USD","ESGY","PBE","IE00BJJMRZ35.SGD","VRTX","FDRX","LU0256863811.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672718956","title":"Sino Biopharmaceutical Stock Falls 2.3% in Hong Kong, Underperforms Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2672718956","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672718956?lang=en_us&edition=fundamental","pubTime":"2026-10-02 16:33","pubTimestamp":1790929980,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Sino Biopharmaceutical Ltd. slid 2.3% to 5.58 Hong Kong dollars on what proved to be an all-around dismal trading session for the Hong Kong stock market, with the Hang Seng Index falling 2.6% to 23972.29.The stock's fall snapped a two-day winning streak.Sino Biopharmaceutical Ltd. closed 35% short of its 52-week high of HK$8.54, which the company achieved Oct. 8.The stock underperformed when compared to some of its competitors, as CSPC Pharmaceutical Group Ltd. fell 1.4% and Amgen Inc. remained unchanged.Trading volume totaled 35.3 million shares, compared to the 50-day average of 80.7 million shares.Data source: Dow Jones Market Data, FactSet","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IBB","BK4533","PBE","IE00BFTCPJ56.SGD","LU0122379950.USD","LU2112291526.USD","BK4566","IE00BZ08YR35.GBP","LU0289739699.SGD","LU1571399168.USD","LU2468319806.SGD","HK0000165453.HKD","LU2089984988.USD","IE00BZ08YS42.EUR","LU0868494617.USD","LU0109394709.USD","BK1515","IE00BJJMRZ35.SGD","IE00B2B36J28.USD","91335","LU1057294990.SGD","SG9999001440.SGD","BK4585","IE0002141913.USD","LU1061106388.HKD","BK4139","IE00B4R5TH58.HKD","IE0009355771.USD","LU0320765992.SGD","BK4534","LU2242646821.SGD","LU0058720904.USD","LU0889565916.HKD","AMGN","BIB","IE00BJT1NW94.SGD","IE00BZ08YT58.USD","BK4599","BBH","BK4588","LU1983299246.USD","LU2242652126.USD","BK4581","BK1191","LU1023059063.AUD","TBXU","BK1521","IBBQ","01177","PJP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672379718","title":"Quantum Computing is Having a Moment. What to Know About the Hottest Sector After AI.","url":"https://stock-news.laohu8.com/highlight/detail?id=2672379718","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672379718?lang=en_us&edition=fundamental","pubTime":"2026-10-02 15:00","pubTimestamp":1790924400,"startTime":"0","endTime":"0","summary":"\"For Amgen, that means tackling high-complexity computational challenges, from making sense of vast, intricate data sets to modeling interactions at the molecular level. Amgen, like others, is looking for \"quantum advantage,\" or the point where quantum systems can complete a useful task more efficiently than the best available classical supercomputers. In theory, quantum advantage doesn't require fully fault-tolerant systems, which detect and correct errors in real time. This milestone remains elusive, as scaling quantum systems makes them increasingly vulnerable to environmental noise.Today's investments are about exploring capabilities and finding practical applications rather than unlocking immediate efficiencies. \"For me, the opportunity isn't necessarily about streamlining operations, but understanding whether it can help us tackle scientific problems that are difficult to solve with today's tools,\" Russell says.Enthusiasm is spreading across the healthcare landscape. Five years a","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2250418816.HKD","BBH","NVDL","NVDU","LU2125909247.SGD","LU0545562505.USD","LU1868836591.USD","LU0528227936.USD","LU0898699433.AUD","09788","LU2931357623.SGD","BK4592","LU1582987597.SGD","GB00BDT5M118.USD","LU1506573853.SGD","LU2210149790.SGD","LU2089985449.USD","MSFY","LU2264538146.SGD","LU0310800379.SGD","LU0426412945.USD","IE0002141913.USD","IE000M9KFDE8.USD","LU0345770308.USD","LU0238689110.USD","LU2092937148.SGD","BK4554","LU2112291526.USD","SG9999014567.USD","LU2746668974.SGD","LU1202635105.USD","LU2360107168.USD","BK4576","HK0000306685.HKD","LU1582987324.SGD","LU2471134879.HKD","SMSFTmain","LU0203201768.USD","LU1236620750.USD","LU0057025933.USD","LU0323591593.USD","BK4535","BK4602","IE000MB6IJN5.SGD","IE00BJLML261.HKD","LU0353189763.USD","LU1074936037.SGD","LU0289960550.SGD","LU1815336760.USD","LU2237443549.SGD","LU1066051811.HKD","MSFD","LU1340139317.AUD","BK4551","LU1883839398.USD","LU2237443465.HKD","LU2361044865.SGD","LU1861127337.USD","LU1242518857.USD","THMR","IE0001KFT4U8.USD","LU0211331839.USD","IE00BLSP4239.USD","LU1280957306.USD","LU0081259029.USD","LU0868494617.USD","SGXZ99366536.SGD","NVDW","LU0820561909.HKD","HK0000320223.HKD","LU2430703178.SGD","LU0210533765.USD","LU1983299246.USD","LU0726765562.USD","WISE","IE0034235303.USD","IE00B3SWFQ91.USD","NVII","HK0000304797.USD","LU2023250330.USD","TTEQ","LU0690374615.EUR","LU0234572021.USD","LU1366192091.USD","NVDQ","LU0314104364.USD","SPTE","LU1923622614.USD","IONQ","LU1674673428.USD","LU0211328371.USD","BK4566","LU1435385759.SGD","TRFK","BK4567","IE00B19Z8X17.USD","LU0211327993.USD","LU2092627202.USD","LU2237443895.HKD","LU2860962120.EUR","RGTU","SG9999014914.USD","LU0792757196.USD","LU2417539215.USD","LU2272731865.HKD","LU2552382132.HKD","LU0348723411.USD","SOXY","LU2452424414.USD","LU2041044095.USD","LU2357305700.SGD","LU1691799644.USD","LU0345768153.USD","IE00BQXX3D17.EUR","LU0557290698.USD","3NVD.UK","MSFX","IE0005OL40V9.USD","LU0708994859.HKD","LU1778281490.HKD","IE00B19Z8W00.USD","LU1181866309.USD","LU0256863811.USD","LU0061474705.USD","LU1821325948.USD","BK4141","LU1718418525.SGD","LU1066053197.SGD","LU1935043536.SGD","SG9999015341.SGD","IE000SO60NU8.SGD","LU0058720904.USD","LU1992135472.HKD","LU2249611893.SGD","LU0310799852.SGD","LU0912757837.SGD","IONX","IE00BFSS8Q28.SGD","LU1839511570.USD","LU2125909916.SGD","LU0133085943.USD","IE0004445015.USD","LU1316542783.SGD","IE00BK4W5L77.USD","LU0950375773.USD","LU0323239441.USD","LU2047632596.USD","SG9999002224.SGD","LU1061106388.HKD","SG9999014559.SGD","LU0823434583.USD","LU1236620834.HKD","LU1670710588.SGD","NVDD","LU2420271590.USD","LU1868837136.USD","LU1400636657.SGD","LU0215105999.USD","LU2023251221.USD","SG9999004303.SGD","NVDX","LU1861558580.USD","CLSE","LU2236285917.USD","LU1934455277.USD","LU2506952170.USD","LU2095319765.USD","LU1116320737.USD","SGXZ81514606.USD","IBX","LU2756315664.SGD","LU1548497426.USD","LU0170899867.USD","LU1582986433.USD","NVD2.UK","LU2896262040.SGD","LU1983260115.SGD","SG9999014906.USD","CMAG","BK4581","IE0000B7K699.USD","LU2381873111.SGD","LU3102509885.SGD","DIPS","LU2290526834.HKD","LU0949170772.SGD","LU2237957902.USD","LU1084165304.USD","IE00BKVL7J92.USD","MSFU","LU1334329650.SGD","IE00BJT1NW94.SGD","LU0957808578.USD","PJP","IE00BN8TJ469.HKD","QBY","QBTX","LU0080751232.USD","LU1791710582.SGD","IE00BKDWB100.SGD","LU1642822529.SGD","LU2592432038.USD","LU0943347566.SGD","LU1057294990.SGD","LU1235294995.USD","SG9999018865.SGD","LU1188199696.SGD","IOYY","LU0320765992.SGD","LU2100268510.USD","LU2111349929.HKD","LU0511384066.AUD","LU0965509010.AUD","LU2211815571.USD","LU0096362180.USD","LU1551013342.USD","LU0689472784.USD","IE00BFXG0V08.USD","LU2242649171.HKD","LU0553294199.USD","ESLG","LU0784383803.USD","IE00BFSS7M15.SGD","LU0823417737.USD","LU1496350502.SGD","LU1861559042.SGD","IE0004445239.USD","LU2237443382.USD","LU2279689827.SGD","NVD3.UK","SG9999001424.SGD","MSFC","BK4612","LU1633808545.USD","LU1989772840.SGD","AMGN","IE00B2B36J28.USD","BK4528","LU1645745479.HKD","LU1043141396.HKD","NVDA","LU2413666699.HKD","LU0354030511.USD","SG9999018857.SGD","BK4549","BK4527","LU0109391861.USD","LU2552382215.SGD","NVIW.SI","LU0708995401.HKD","IE000ITXATA3.USD","BK4533","LU0879622024.SGD","LU1066051225.USD","LU0266013472.USD","IE00B3M56506.USD","LU2458330169.SGD","RGTC","BK4504","LU0494093205.USD","LU1037948897.HKD","LU0198837287.USD","LU1674673691.USD","LU0265550946.USD","LU2404859741.USD","LU0308772762.SGD","LU2065170008.USD","FDTX","LU1366333091.USD","LU0994945656.USD","LU2362540622.SGD","LU0124676726.USD","LU1196500208.SGD","IE0004091025.USD","LU0345769631.USD","BK4591","SG9999002232.USD","LU1235295455.SGD","SG9999015358.SGD","AGOX","LU2125154935.USD","LU2602419157.SGD","LU0719512351.SGD","GB00B4QBRK32.GBP","NVDS.UK","04332","SKYY","LU0820561818.USD","LU0395794307.EUR","LU0894485498.HKD","LU1989772923.USD","LU1935043023.USD","LU2347655073.USD","LU2168564222.USD","IE0009355771.USD","LU0640476718.USD","NVC","IBB","LU0053666078.USD","LU1868837300.USD","LU2487616109.SGD","LU2764263039.SGD","LU0061474960.USD","SMHX","LU0861579265.USD","LU2463028550.USD","MSFT","IE00B5TLWC47.USD","IE00B4JS1V06.HKD","IE00B7KXQ091.USD","IE00BJJMRY28.SGD","LU0724617625.USD","IE00B4R5TH58.HKD","IE00BFTCPJ56.SGD","LU0072461881.USD","LU0154236417.USD","LU0949170426.SGD","LU1221951129.SGD","XLK","LU2506951792.HKD","LU1803068623.USD","LU2505996681.GBP","LU1564329628.SGD","LU2433249047.HKD","LU2764263203.CNY","LU0079474960.USD","LU1629891620.HKD","IE0034235188.USD","LU0070217475.USD","NVDB","LU1989764664.SGD","LU2242650005.HKD","LU0289739343.SGD","LU0859254822.USD","LU0128525929.USD","WQTM","LU0094547139.USD","LU1720051108.HKD","GB00B4LPDJ14.GBP","LU1861215975.USD","LU0683600562.USD","LU1989764748.USD","IBM","JGRO","IE000WAW04H5.SGD","LU1935042991.SGD","LU0444973449.USD","BK4587","QBTS","LU1244550494.USD","LU2087621335.USD","EFIV","IE00BZ1G4Q59.USD","LU0289941410.SGD","IE00BBT3K403.USD","LU1267930730.SGD","LU0347712357.USD","LU2168564149.EUR","LU0256863902.USD","LU2089984988.USD","LU2361044949.HKD","LU0795875086.SGD","LU2404859667.USD","LU2750360997.AUD","SG9999014898.SGD","IE0002270589.USD","BK4575","IE0009G5SDU7.USD","LU2237438978.USD","IE0003U64NQ7.SGD","IE00BD6J9T35.USD","LU2089283258.USD","LU1145028129.USD","NULC","LU2491050154.USD","LU1914381329.SGD","IE00BDRTCR15.USD","LU1221951046.USD","LU0345774391.USD","LU2473716301.USD","LU1267930490.SGD","BK4543","IE00BQXX3F31.USD","MSFW","LU0786609619.USD","LU0314106906.USD","LU0345768740.USD","IE00B19Z9505.USD","LU0302445910.USD","LU2108987350.USD","LU1732800096.USD","LU2065171311.SGD","LU2168563687.JPY","IXN","LU2023250504.SGD","LU1582986359.USD","LU2362541273.HKD","LU1564329032.USD","LU0979878070.USD","LU1815333072.USD","LU2237443978.SGD","IBBQ","IE00BKPKM429.USD","SOXQ","BK4170","LU2054465674.USD","LU0661504455.SGD","IONL","LU0784385840.USD","LU2242646821.SGD","LU0069063385.USD","BK4532","IE00B19Z3581.USD","LU2065169927.USD","LU1069344957.HKD","CQTM","LU2360106780.USD","LU2746668461.USD","HK0000914686.HKD","LU0871640123.AUD","LU0175139822.USD","LU1988902786.USD","LU2168564065.EUR","IE00BSNM7G36.USD","NVDS","IE00BN29S564.USD","SGXZ23171101.USD","SG9999000418.SGD","IE00BK4W5M84.HKD","LU2456880835.USD","SMH","LU0143551892.USD","LU0889565916.HKD","SNVDAmain","LU0476273544.USD","LU0056508442.USD","IE000BZT7R73.USD","SIBM0main","LU0208291251.USD","LU0889565833.HKD","LU2360108059.USD","BK4503","HK0000914660.USD","LU0894486033.HKD","LU0171293334.USD","LU1144417596.USD","BK4097","LU0426417589.USD","LU1003077747.HKD","LU0788109477.HKD","LU1119994496.HKD","LU0820562030.AUD","LU1301847155.USD","LU1923622291.USD","ROM","LU0323240290.USD","LU0784385170.HKD","LU0265550359.USD","LU0795875169.SGD","LU0011850046.USD","HK0000320264.USD","LU1823568750.SGD","LU0162691827.USD","LU1880398554.USD","LU2413666426.HKD","SGXZ31699556.SGD","TYLG","LU2213496289.HKD","LU1571399168.USD","LU2999663052.SGD","BK4139","LU2125909759.SGD","SG9999015945.SGD","IE00BMPRXN33.USD","GAMR","LU1670711123.USD","LU1232071149.USD","NVDY","VGT","NVYY","LU0109392836.USD","TTXU","LU2403377893.USD","LU2347655156.SGD","IE000KEQY171.SGD","SG9999014575.USD","LU1670711040.USD","BK4585","LU2272731782.SGD","LU1934455194.USD","LU2077746001.SGD","LU2125154778.USD","SNVD.UK","IE00B19Z3B42.SGD","OGIG","IE00BJTD4N35.SGD","LU1429558221.USD","LU0345774631.USD","LU0545039389.USD","LU1127390331.HKD","IE00B5949003.HKD","IE00BWXC8680.SGD","LU1323610961.USD","LU1623119135.USD","SG9999014880.SGD","LU2720916845.USD","BK4588","SG9999014542.SGD","LU2764262908.HKD","LU2458330243.SGD","LU2087625088.SGD","LU2468319806.SGD","RGTZ","ILDR","BK4548","LU1116320901.HKD","MSFL","LU1564329115.USD","PBE","CHPX","LU1035773651.USD","LU0444971666.USD","IE0034235295.USD","LU0985320562.USD","IE000Q6AESB8.SGD","IGV","LU1267930813.SGD","LU1035775433.USD","LU1935043452.HKD","LU2756315318.SGD","IE00BLSP4452.SGD","LU2357627491.SGD","BK4598","LU0289961442.SGD","IE00B4YYXB79.USD","LU2543165471.USD","BK4614","LU0157215616.USD","LU1496350171.SGD","LU0234570918.USD","IE00BDCRKT87.USD","LU0390134368.USD","LU2471134796.USD","LU2430703251.USD","LU1228905037.USD","IE00BJTD4V19.USD","LFGY","IE00BMPRXR70.SGD","LU1894683264.USD","LU0107464264.USD","LU2023250843.SGD","MSFO","LU1244550577.SGD","LU2505996509.AUD","TBXU","BK4608","LU0823434740.USD","LU0187121727.USD","SG9999015952.SGD","IE00BQXX3C00.GBP","LU0889566641.SGD","LU0138981039.USD","LU1951198990.SGD","SGXZ80539844.SGD","USXF","LU0960925559.SGD","IE00B1BXHZ80.USD","SG9999017495.SGD","LU2247934214.USD","LU2461242641.AUD","IE00BHPRN162.USD","LU1880398471.USD","NVDG","LU0466842654.USD","IE00BFXG1179.USD","VT","BK4550","LU1046421795.USD","LU1852331112.SGD","LU2102340556.USD","LU0158827948.USD","LU2028103732.USD","LU2506951958.HKD","HK0000306701.USD","LU2506951875.HKD","IE00BYXW3230.USD","LU2361045086.USD","LU0345769128.USD","LU2083900584.USD","LU2491049909.HKD","LU0823421416.USD","LU0965509101.SGD","IE00BMPRXQ63.HKD","LU2462157665.USD","QTUP","SNPE","LU2244417387.USD","LU2430703095.HKD","LU0757359954.USD","LU1670710661.SGD","LU1732799900.SGD","LU0061475181.USD","BK4538","AIFD","LU0109394709.USD","SOXX","RGTI","LU2089284900.SGD","HK0000532082.HKD","IETC","07788","IE00BZ199S13.USD","LU1064131342.USD","LU0210536198.USD","CNEQ","BK4529","BK4605","BK4599","LU0106261372.USD","LU0868494708.USD","LU1032466523.USD","LU1934455863.HKD","IE00BJJMRX11.SGD","LU2286300806.USD","TEK","IE000YTNTUN2.SGD","BK4023","LU1564329461.SGD","LU1066051498.USD","LU0689626769.HKD","LU1400636574.HKD","LU1228905540.USD","IE0004086264.USD","NVDO","09388","QBTZ","LU0077335932.USD","LU1244550221.USD","LU0472753341.HKD","BK4579","LU1023059063.AUD","LU1720051017.SGD","LU0321505868.SGD","LU1861220033.SGD","LU1059921491.USD","LU2242652126.USD","LU2750360641.GBP","NVD","07388","LU1585245621.USD","LU2462591277.SGD","BK4134","LU0127658192.USD","LU2210150020.SGD","LU1032955483.USD","LU0456855351.SGD","IE00BJJMRZ35.SGD","SG9999015986.USD","LU1814569148.SGD","LU2106854487.HKD","SGXZ51526630.SGD","LU2063271972.USD","LU1989763005.USD","SHOC","IE00B775H168.HKD","LU0095938881.EUR","LU2471134523.USD","LU1551013425.SGD","LU2092937221.SGD","LU1267930573.SGD","LU0320765059.SGD","LU1951200564.SGD","LU0823414478.USD","LU2298321311.HKD","LU1430594728.SGD","LU2237957811.SGD","LU2322448957.HKD","TDIV","LU0642271901.SGD","IE00B775SV38.USD","LU2133065610.SGD","IE00BYQQ9H92.USD","LU0321505439.SGD","IONZ","LU0203202063.USD","BK4577","LU0072462426.USD","LU1037948541.HKD","LU0823417653.USD","LU1721428933.USD","LU0353189680.USD","LU1868836757.USD","IE0009356076.USD","LU1979441026.SGD","LU2506952097.USD","LU2272731600.USD","LU0289739699.SGD","LU0225283273.USD","FTEC","LU0251132253.USD","LU2294711713.HKD","LU0957791311.USD","LU2360032135.SGD","LU0276348264.USD","USD","LU2462591350.SGD","LU0274383776.USD","LU0690374961.EUR","LU0174119429.USD","LU1697837992.HKD","SG9999001077.SGD","LU1153585028.USD","LU1917777945.USD","LU2125909593.SGD","RGTX","BK4534","LU0149725797.USD","LU2265009873.SGD","BK4525","LU2168564495.EUR","IE000F7OJYX1.SGD","LU2552382058.USD","LU2322448791.USD","LU0417517546.SGD","LU0757359368.USD","LU0784384876.USD","LU1712237335.SGD","BK4516","LU0096364046.USD","LU2097829019.USD","HK0000819398.USD","LU0965509283.SGD","BIB","LU0006306889.USD","LU1670627923.USD","ANV","LU2191332357.HKD","LU1935042488.USD","FAI","LU0738911758.USD","IE000W1ABFV2.USD","LU1699723380.USD","QUA","LU0029864427.USD","LU0345770993.USD","LU2471134952.CNY","HK0000304805.HKD","LU0823421333.USD","LU0048584097.USD","LU0965508806.USD","ESUM","LU2065171402.SGD","LU2097344431.USD","LU0082616367.USD","LU0942090050.USD","LU1043141123.HKD","LU2097344357.USD","LU0316494557.USD","LU1670756490.USD","LU2148611432.USD","LU1670628061.USD","LU1791710400.SGD","LU0312595415.SGD","IE00B1XK9C88.USD","LU0158827781.USD","LU2271345857.HKD","LU0320765489.SGD","LU2637965513.SGD","AIPI","LU1803068979.SGD","LU1923623000.USD","LU1242518931.SGD","LU2394011477.USD","LU0787776722.HKD","LU0267386448.USD","LU1121112475.USD","LU0122379950.USD","LU0070302665.USD","LU2326559502.SGD","SG9999015978.USD","LU2491050071.SGD","LU1804176565.USD","LU0882574139.USD","LU1974910355.USD","RGYY","2NVD.UK","LU1400636491.USD","SG9999001440.SGD","METV","LU2362541513.USD","LU1894683348.USD","LU2237443622.USD","LU1992135399.USD","LU0672654240.SGD","LU1989773731.SGD","LU2954938101.SGD","LU2357125470.USD","LU0097036916.USD","LU1868836914.USD","IONC","LU2275660780.HKD","LU0342679015.USD","IE00B3S45H60.SGD","LU1261432733.SGD","LU1935042215.USD","LU1069347547.HKD","LU0210528500.USD","LU0823414551.USD","LU0354030438.USD","ABFL","LU0964807845.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":1,"totalSize":200,"code":"91000000","status":"200"}]}}